SCHEMBL30079447

SCHEMBL30079447

COc1nccc(C(F)(F)F)c1N1CCC2(CC1)OCCO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.39
HTT P42858 1/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 4/20 0.36
MAPT P10636 3/20 0.36
C5AR1 P21730 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CES2 O00748 1/20 0.36
POLB P06746 2/20 0.36
KMT2A Q03164 2/20 0.35
MAPK8 P45983 1/20 0.35
MAPK10 P53779 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.34
HCRTR1 O43613 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30079311 0.82 MAPK8 (0.44) ALDH1A1HTTLMNAKDM4EMAPT
SCHEMBL30079314 0.81 ALDH1A1 (0.41) ALDH1A1HTTLMNAKDM4EMAPT
SCHEMBL30079400 0.79 C5AR1 (0.44) C5AR1
SCHEMBL30079417 0.77 C5AR1 (0.42) ALDH1A1HTTLMNAMAPTC5AR1
SCHEMBL17893838 0.68 MAPT (0.47) ALDH1A1HTTLMNAKDM4EMAPT
SCHEMBL2273685 0.68 LGMN (0.44) ALDH1A1HTTKDM4EMAPTNPSR1
SCHEMBL17893793 0.67 ALDH1A1 (0.45) ALDH1A1LMNAKDM4EMAPTNPSR1
SCHEMBL609770 0.66 ALDH1A1 (0.41) ALDH1A1HTTLMNAKDM4EMAPT
SCHEMBL17893645 0.66 DPP4 (0.44) ALDH1A1KDM4EMAPTPOLBKMT2A
SCHEMBL24246943 0.66 SLC22A12 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737684-B1 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES IDORSIA PHARMACEUTICALS LTD (CH) 2022-11-16 EP disclosed